# Study Evaluating the Pharmacokinetic Profile of Novel Formulations of RHUDEX®

> **NCT01500122** · PHASE1 · COMPLETED · sponsor: **MediGene** · enrollment: 12 (estimated)

## Conditions studied

- Formulation Finding

## Interventions

- **DRUG:** RhuDex

## Key facts

- **NCT ID:** NCT01500122
- **Lead sponsor:** MediGene
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2011-12
- **Primary completion:** 2012-03
- **Final completion:** 2012-06
- **Target enrollment:** 12 (ESTIMATED)
- **Last updated:** 2012-06-21


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01500122

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01500122, "Study Evaluating the Pharmacokinetic Profile of Novel Formulations of RHUDEX®". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT01500122. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*